Skip navigation

Leadership Seminar: Respiratory and Inflammatory Diseases

10:00 - 18:00

Location:
Penningtons Manches, 125 Wood Street, London EC2V 7AW
Date:
22 September 2016
 
Sponsored by





Hosted by 



With a rising prevalence of chronic respiratory conditions such as asthma and COPD (expected to become the third leading cause of death globally by 2030), an ageing population and expensive treatment options, respiratory is one of therapeutic areas to watch. It cumlates maturity and potential for innovation especially with the rise of combination drugs and improved delivery systems.


This Leadership Seminar will provide an overview of the current clinical challenges in Respiratory and Inflammatory Diseases and insights on how to address them with presentations of current and innovative therapeutic options.    

The event is aimed at anybody with an interest in the field of Respiratory and Inflammation including academics and early stage companies who could use this forum to identify research gaps where their technology could fit.

Click here to view Respiratory market data. 

Programme:

10.00 - Registration opens

10.20 - Welcome from the host

10.30 - Introduction 
Adrian Dawkes, PharmaVentures

Click here to see the presentation


10.45 – Keynote presentations and discussion on unmet clinical needs including:

10.45 - Symptoms vs Disease modification Approach
Lars Larson, TranScrip
Click here to see the presentation

11.05 Prospects for the prevention and treatment of respiratory virus-induced exacerbations in asthma and COPD 
Garth Rapeport, Pulmocide 
Click here to see the presentation

11.25 Eosinophil depletion with benralizumab (anti-IL-5R) for the management of Severe Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Suzanne Cohen, MedImmune

11.45 Breath Biopsy - Breath Volatile Organic Compounds (VOCs) as markers for respiratory disease 
Billy Boyle, Owlstone Medical


12.05
 Panel discussion and Q&A


12.30 - Lunch and networking 

14.00 – Innovation in Clinical development 

14.00 Connected Devices: Protecting Personal Data

Oliver Bett, Penningtons Manches

Click here to see the presentation

14.20 Adaptive Design in Respiratory Clinical Trials – A Sponsor’s Business Case 
Alethea Wieland, Scope International
Click here to see the presentation

14.40 Development of immunoassays and point-of-care tests for the measurement of active protease biomarkers of chronic respiratory disease
David Ribeiro, ProAxsis
Click here to see the presentation

15.00 Aiming for the Lungs - Formulation Strategies for Delivery of Inhaled Biologics
Charlotte Yates, Vectura

Click here to see the presentation


15.30 - Tea, coffee and networking


16.00 – Innovative therapeutic options

16.00
The Development of an IL-17BR therapeutic antibody for the treatment of Asthma and IPF
David Matthews, MRCT

16.20 Mycobacterium tuberculosis derived Peptide as a Disease Modifying Therapy for Asthma
Nicky Cooper, Peptinnovate

16.40 – Closing Remarks and Drinks Reception

18.00 - end


Cost:

Gold members and academic rate - £75
Silver members – £175
Non-members - £275


Please email aline@onenucleus.com to get your academic discount code’
Title: Leadership Seminar: Respiratory and Inflammatory Diseases
Start: 2016-09-22 10:00:00Z
End: 2016-09-22 18:00:00Z